Subjects: PROTEINURIA; IMMUNOSUPPRESSIVE agents; LUPUS nephritisUNITED States. Food & Drug Administration
Record details
Subjects: RISK assessment; PROTEINURIA; RESEARCH funding
Subjects: KIDNEY physiology; DRUG efficacy; PROTEINS
Subjects: CRITICALLY ill; CITRATES; ANTICOAGULANTS
Subjects: SKIN diseases; HOSPITAL emergency services; SCIENTIFIC observationITALY
Subjects: CHILD patients; CHOLANGITIS; CEFTRIAXONE
Subjects: SUPRAVENTRICULAR tachycardia; ERYTHROCYTES; LYMPHOCYTE count